Alkermes (ALKS)
(Delayed Data from NSDQ)
$27.32 USD
-0.31 (-1.12%)
Updated Jul 31, 2024 04:00 PM ET
After-Market: $27.30 -0.02 (-0.07%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth A Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
ALKS 27.32 -0.31(-1.12%)
Will ALKS be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for ALKS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ALKS
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
ALKS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Why Alkermes (ALKS) is a Top Value Stock for the Long-Term
Why Alkermes (ALKS) is a Top Value Stock for the Long-Term
Alkermes' (ALKS) Q2 Earnings Miss Estimates, Revenues Beat
Other News for ALKS
Alkermes: Fairly Valued After Post-Earnings Bump
Maintaining Hold on Alkermes: Weighing Solid Performance Against Seasonal Slowdown and Pipeline Uncertainties
Alkermes PLC (ALKS) Q2 2024 Earnings Call Transcript Highlights: Strong Revenue Growth Amid ...
Strong Buy on Alkermes: Solid Q2 Earnings and Promising Drug Pipeline Drive Positive Outlook
Alkermes price target raised by $1 at Baird, here's why